McGill University Medical Podcast Series
Devin Abrahami - DPP-4 inhibitors and incidence of IBD among patients with DMII


Published online: 16 May 2018
1 Faculty of Medicine, McGill University, Montréal, Canada.
Corresponding Author: Russel Yanofsky, email russ.yanofsky@gmail.com.

Episode 2

On this episode we're very grateful to have interviewed PhD candidate Devin Abrahami, the first author of the paper "Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study" published in the March 2018 issue of the British Medical Journal. This paper from the group of Dr. Laurent Azoulay really made a lot of waves in the medical community, achieving an Altmetric score of 320 and still climbing and is a must-read.

Article: Abrahami D, Douros A, Yin H, Yu OHY, Renoux C, Bitton A, et al. Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study. BMJ. 2018 Mar 21;360:k872. 10.1136/bmj.k872